Clinical trials – Leukaemia Care e-learning

Clinical trials comparing new treatments with existing treatment are ongoing. If patients meet the inclusion criteria, this may be an option for them to access new treatments if the currently used treatment are not working.
Details of all clinical trials in patients with ALL can be found at https://clinicaltrials.gov/ct2/show/. These trials include investigations of new target drugs, CAR-T-cell therapies, and various drug regimens for relapsed or refractory ALL, which include the monoclonal antibody blinatumomab.